PBLA Panbela Therapeutics

Sun BioPharma Inc. engages in the development of disruptive therapeutics for medical purposes. It focuses on development programs that target diseases of the pancreas, including pancreatic cancer and pancreatitis. The company was founded by Michael Cullen and Thomas Neenan on September 21, 2011 and is headquartered in Waconia, MN.

Company profile

Michael Cullen
Fiscal year end
Former names
Cimarron Medical, Inc., CIMARRON SOFTWARE INC, Sun BioPharma, Inc.

PBLA stock data


Investment data

Data from SEC filings
Securities sold
Number of investors


24 Mar 21
17 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 9.02M 9.02M 9.02M 9.02M 9.02M 9.02M
Cash burn (monthly) 616K (positive/no burn) 533.67K 480.58K 371K 321.17K
Cash used (since last report) 2.2M n/a 1.9M 1.71M 1.32M 1.15M
Cash remaining 6.82M n/a 7.12M 7.31M 7.7M 7.88M
Runway (months of cash) 11.1 n/a 13.3 15.2 20.8 24.5

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
30 Mar 21 Michael T. Cullen Employee Stock Option Common Stock Grant Aquire A No No 4.09 55,000 224.95K 55,000
30 Mar 21 Gagnon Suzanne Employee Stock Option Common Stock Grant Aquire A No No 4.09 35,000 143.15K 35,000
30 Mar 21 Simpson Jennifer K. Employee Stock Option Common Stock Grant Aquire A No No 4.09 170,000 695.3K 170,000
30 Mar 21 Horvath Susan Employee Stock Option Common Stock Grant Aquire A No No 4.09 40,000 163.6K 40,000
1 Dec 20 Fratamico Arthur Common Stock Grant Aquire A No No 0 2,875 0 5,299

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 0 6 EXIT
Opened positions 0 5 EXIT
Closed positions 5 0 NEW
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 0 1.02M EXIT
Total shares 0 340.12K EXIT
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Largest transactions
Shares Bought/sold Change
Worth Venture Partners 0 -123.64K EXIT
CVI 0 -79.03K EXIT
Essex Investment Management 0 -76.77K EXIT
Verition Fund Management 0 -60.61K EXIT
Tower Research Capital 0 -81 EXIT
Proequities 0 0
Content analysis
H.S. sophomore Avg
New words: Advisor, affiliate, agriculture, Allergan, alleviate, analyzed, arose, background, Bekaert, biotech, Bloomington, Blvd, Boston, Casero, category, Cerecor, chair, Champion, Chapter, character, checkpoint, Cherry, combat, composed, conference, conferred, conflict, consummated, corn, counter, County, CRNP, cut, cutoff, deal, dealing, decade, decentralized, dedicated, Delcath, depletion, dismutase, distressed, Drexel, Eagle, elevated, Eli, eNeura, eye, farming, fiduciary, forgiven, Galera, Garry, Gemin, Gemphire, graduate, graduated, headcount, Heart, higher, highest, ImClone, immune, immunology, indirect, inhibitory, innovative, inquired, insight, insulate, interference, interrupted, Janssen, jennifer, Kandiyohi, launch, leadership, learn, lesser, lifted, Lilly, literacy, logical, Lycera, Madeline, matter, microenvironment, mid, migraine, month, mother, MSN, nephrology, neurological, NeuroOne, nominating, nurse, Ortho, overseen, owner, panbela, pause, paused, Paycheck, payroll, PBLA, petition, pharmacist, PharmD, Phenix, Philadelphia, poster, PPP, practitioner, pre, prorated, prospective, pure, radiologic, radiotherapy, Ramucirumab, ratified, ratify, rational, raw, reauthorized, recondition, recuse, rent, reopen, resourcing, restarted, retrospective, SBR, serial, settlement, Shaffer, simpson, Society, spouse, spring, staffing, Subtopic, sugar, Teewinot, transformed, transforming, ValAdCo, visual, Vitae, VStock, wage, wealth, yearend
Removed: acid, adjuvant, allocate, analyst, announced, Appointment, ASC, bid, borrowed, bought, broker, buy, cancelled, categorized, closing, complied, contested, core, deemed, deficit, delaying, denied, deterring, digestive, diminish, direction, domestic, efficiently, enterprise, exchanged, exemption, expanding, explored, feel, folic, formation, formulate, frame, hire, holder, incorporate, inefficiency, influencing, intangible, joint, licensor, liquid, mature, maturity, media, minimal, movement, occurrence, optimally, organized, partnership, penny, possession, proposal, quotation, representing, resell, retail, revised, safely, secondary, segment, Similarly, standardized, stringent, supervise, tangible, train, unaffected, unamortized, understood, unpaid, venture, volatile